Vaxcyte

Vaxcyte FCF per Share

The Free Cash Flow per Share of Vaxcyte (PCVX) as of Oct 11, 2026 is -4.92 USD. In the previous year, Free Cash Flow per Share was -3.87 USD — a change of 27.18% (lower).

FCF per Share

-4.92USD

YoY

27.18%

Last updated:

Free Cash Flow per Share of Vaxcyte is 2025 -4.92 USD. Free Cash Flow per Share of Vaxcyte was 2024 -3.87 USD. It decreases by 27.18% lower compared to the previous year.

The Vaxcyte FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-8.06 USD
Jan 1, 2019
-1.91 USD
Jan 1, 2020
-0.94 USD
Jan 1, 2021
-2.34 USD
Jan 1, 2022
-2.34 USD
Jan 1, 2023
-3.49 USD
Jan 1, 2024
-3.87 USD
Jan 1, 2025
-4.92 USD
The Vaxcyte FCF per Share history
YEARFCF per ShareYoY
-4.92USD+27.18%
-3.87USD+10.74%
-3.49USD+49.52%
-2.34USD-0.08%
-2.34USD+149.32%
-0.94USD-50.97%
-1.91USD-76.27%
-8.06USD+177,450.72%
-0.00USD—
Access this data via the Eulerpool API
Get Free API Key

Vaxcyte Stock analysis

What does Vaxcyte do? Vaxcyte Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of vaccines for various diseases. The company was founded in 2018 and is headquartered in Foster City, California. Vaxcyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vaxcyte stock

Free Cash Flow per Share of Vaxcyte is -4.92 USD in 2025.

Free Cash Flow per Share of Vaxcyte changed from -3.87 USD to -4.92 USD, representing a 27.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Vaxcyte since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Vaxcyte

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Vaxcyte